The histone variant H3.3, an ancient and evolutionarily conserved protein that packages DNA, has long presented a puzzle to scientists due to its dual nature. While known to be present at active gene regions to facilitate expression, it is also found embedded within dense, repressive structures of the genome known as heterochromatin. How the same protein can be involved in such opposing functions remained unclear.
Previous work had hinted at a clue: the chemical modification of H3.3 at a specific site, serine 31 (Ser31p). Yet, its precise role in forming the repressive heterochromatin, especially marked by another modification called H3K9me3, was poorly understood. Similarly, while the silencing of one X chromosome in females—a classic example of large-scale epigenetic regulation—requires heterochromatin, the involvement of H3.3 and its Ser31p modification in this vital process was unknown.
To solve this mystery, a team of researchers employed a combination of cutting-edge techniques. They began by identifying proteins that specifically bind to H3.3-containing nucleosomes. Their search revealed a key player: CBX7, a core component of the well-known Polycomb repressive complex.
The study made a critical discovery: H3.3's recruitment of CBX7 is not random. It depends on a dual chemical signal—the simultaneous presence of the phosphorylation at serine 31 (H3.3Ser31p) and another modification, the trimethylation at lysine 27 (H3.3K27me3). When the researchers genetically engineered cells to disrupt either of these modifications or CBX7's ability to read them, the recruitment of CBX7 to chromatin dropped dramatically across the genome.
Intriguingly, disrupting this H3.3-CBX7 interaction did not affect the classic repression marks typically associated with Polycomb complexes. Instead, it specifically caused a global decrease in H3K9me3, the hallmark of a major class of heterochromatin. This indicated that H3.3-bound CBX7 was functioning in a novel pathway dedicated to establishing H3K9me3-based silencing.
The researchers then traced the next step in this pathway. They found that CBX7 directly interacts with KAP1, a master scaffolding protein essential for H3K9me3 deposition. Importantly, mutations that broke the H3.3-CBX7 link also prevented KAP1 from properly localizing to chromatin. This established a clear chain of command: the dual mark on H3.3 (Ser31p+K27me3) recruits CBX7, which in turn recruits KAP1 to lay down the H3K9me3 repressive mark.
To demonstrate the physiological importance of this newly discovered “H3.3–CBX7–KAP1–H3K9me3” axis, the team turned to X-chromosome inactivation (XCI). They found that this cascade is absolutely essential for building the H3K9me3-rich heterochromatin on the inactive X chromosome. Mutations that disrupted the H3.3-CBX7 interaction completely blocked H3K9me3 accumulation during XCI, and follow-up experiments confirmed that H3.3 Ser31 phosphorylation is a non-redundant, indispensable signal for this process.
In summary, this work resolves a long-standing paradox in epigenetics. It reveals how the histone variant H3.3, through a specific dual modification, acts as a central switch. By initiating the sequential “H3.3–CBX7–KAP1” pathway, it directs the establishment of repressive H3K9me3 heterochromatin. This mechanism is crucial for two fundamental biological events: silencing genomic “parasites” like retrotransposons and executing the precise epigenetic silencing of an entire X chromosome. These findings provide a novel framework for understanding how chromatin states are dynamically controlled in development and disease, and highlight the H3.3-CBX7 interface as a potential target for therapies aimed at correcting epigenetic dysregulation.
This research was a collaborative effort among the laboratories of Dr. Guohong Li (College of Life Sciences, Wuhan University), Dr. Ying Huang (Xinhua Hospital, Shanghai Jiao Tong University School of Medicine), Dr. Yang Yu (Guangzhou Women and Children's Medical Center, Guangzhou Medical University), and Dr. Aiwu Dong (School of Life Sciences, Fudan University).
Science Bulletin
Experimental study